首页 工具
登录
购物车
Nandrolone decanoate

Nandrolone decanoate

产品编号 T2556   CAS 360-70-3
别名: 癸酸诺龙, 19-Nortestosterone decanoate

Nandrolone decanoate (19-Nortestosterone decanoate) 是一种合成代谢雄激素,通过涉及谷氨酸诱导的 N-甲基-D-天冬氨酸受体过度兴奋的机制诱导攻击性行为表征。

TargetMol的所有产品和服务仅用于科学研究,不能被用于人体,我们也不向个人提供产品和服务。
Nandrolone decanoate Chemical Structure
Nandrolone decanoate, CAS 360-70-3
规格 价格/CNY 货期 数量
5 mg ¥ 287 现货
10 mg ¥ 407 现货
25 mg ¥ 665 现货
50 mg ¥ 981 现货
100 mg ¥ 1,460 现货
200 mg ¥ 2,200 现货
500 mg ¥ 3,550 现货
1 mL * 10 mM (in DMSO) ¥ 278 现货
千万补贴 助力科研
BCA蛋白浓度测定试剂盒限时半价
重组蛋白限时优惠
Doxorubicin hydrochloride限时半价
产品目录号及名称: Nandrolone decanoate (T2556)
点击图片重新获取验证码
选择批次  
纯度: 99.68%
纯度: 99.03%
TargetMol batch loading
更多批次查询请联系客服
生物活性
化学信息
存储 & 溶解度
参考文献
产品描述 Nandrolone decanoate (19-Nortestosterone decanoate) is the decanoate salt form of nandrolone, an anabolic steroid analog of testosterone with androgenic, anabolic, and erythropoietin stimulating effects. Nandrolone enters the cell and binds to and activates specific nuclear androgen receptors in responsive tissue, including the prostate, seminal vesicles, scrotum, penis, larynx, hair follicles, muscle, and bone.
体外活性 The anabolic steroid nandrolone decanoate with the used concentrations, is not able to change the viability of muscle cells during the in vitro differentiation process[2].
体内活性 High nandrolone decanoate doses lead to decreased serum glucose, accompanied by high serum insulin levels during fasting. Glucose production rate and liver glycogen content are decreased by the chronic administration of nandrolone decanoate, probably resulting in decreased fasting glucose[1]. In vivo studies demonstrate that the effects of nandrolone decanoate depended on the assessed muscles, time of treatment, dose and association or not with exercises. All of these are able to cause increased muscle mass, alterations in the cell cycle, bone mineral density, bone growth, and the ARs influence these effects[2].
激酶实验 Affinity assay: The affinity of Aclidinium for the different human muscarinic receptor subtypes at equilibrium is determined by measuring their ability to displace the binding of [3H]NMS to cell membrane preparations expressing one of the human muscarinic receptor subtypes. Protein concentrations are 8.1 μg/well, 10.0 μg/well, 4.9 μg/well, 4.5 μg/well, and 5.0 μg/well for M1, M2, M3, M4, and M5 receptor membrane preparations, respectively. The assays are conducted at [3H]NMS concentrations approximately equal to the radioligand equilibrium dissociation constant (Kd) for the different muscarinic receptors subtypes. The [3H]NMS concentration is 0.3 nM for the M1 and M4 assays and 1 nM for the M2, M3, and M5 assays. A range of antagonist concentrations (10?14 to 10?5 M) are tested in duplicate to generate competition curves. Nonspecific binding is determined in the presence of atropine (1 μM). Assay reagents are dissolved in assay binding buffer (phosphate-buffered saline with calcium and magnesium) to a total volume of 200 μL. After a 2 hours or 6 hours incubation period (M1–M4 and M5, respectively) at room temperature in 96-well microtiter plates to ensure that equilibrium is achieved for Aclidinium, 150 μL aliquots of the reaction are transferred to GF/C filter plates pretreated for 1 hour with wash buffer (50 mM Tris, 100 mM NaCl, pH 7.4) containing 0.05% polyethylenimine. Bound and free [3H]NMS are then separated by rapid vacuum filtration followed by four washes with ice-cold wash buffer. Filters are then dried for 30 min before addition of 30 μL of OptiPhase Supermix, and radioactivity is quantified using a MicroBeta Trilux microplate scintillation counter.
细胞实验 Cell viability is assessed one, three and five days after incubation with nandrolone decanoate at the final concentrations of 5, 10, 25 and 50 µM or the drug vehicle (1.5:1-benzyl alcohol/peanut oil), added in different amounts according to the anabolic concentrations (vehicle 5, 10, 25 and 50 µM, respectively). Together with the treatment with the anabolic steroids, 2% horse serum was added to the culture for the induction of differentiation of muscle cells. (Only for Reference)
别名 癸酸诺龙, 19-Nortestosterone decanoate
分子量 428.65
分子式 C28H44O3
CAS No. 360-70-3

存储

Powder: -20°C for 3 years | In solvent: -80°C for 1 year

溶解度

DMSO: 4.29 mg/mL (10 mM)

溶液配制表

可选溶剂 浓度 体积 质量 1 mg 5 mg 10 mg 25 mg
DMSO 1 mM 2.3329 mL 11.6645 mL 23.3291 mL 58.3226 mL
5 mM 0.4666 mL 2.3329 mL 4.6658 mL 11.6645 mL
10 mM 0.2333 mL 1.1665 mL 2.3329 mL 5.8323 mL

TargetMol Calculator计算器

摩尔浓度计算器
稀释计算器
配液计算器
分子量计算器
=
X
X
X
=
X
=
/
g/mol

输入分子式,点击计算,可计算出产品的分子量。

TargetMol Library Books参考文献

1. Frankenfeld SP, et al. J Endocrinol. 2014, 220(2):143-153. 2. Beatriz Guimaraes Ribeiro, et al. Fisioter Pesq. 2014, 21(1):16-20.
BI 224436 (S)-BI-1001 HIV-1 inhibitor-53 Elsulfavirine DRB InteriotherinA BMS-378806 BRD-6929

相关化合物库

该产品包含在如下化合物库中:
药物功能重定位化合物库 抗COVID-19化合物库 抗病毒库 儿童药物库 抗感染化合物库 人代谢物化合物库 FDA 上市药物库 NO PAINS 化合物库 已知活性化合物库 上市药物库

TargetMol Calculator剂量换算

对于不同动物的给药剂量换算,您也可以参考 更多...

TargetMol Calculator 体内实验配液计算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。

母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。

体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。

第一步:请输入动物实验的基本信息
剂量
mg/kg
每只动物体重
g
给药体积
μL
动物数量
第二步:请输入动物体内配方组成,不同的产品配方组成不同,如有配方需求,可先联系我们提供正确的体内配方。
% DMSO
%
% Tween 80
% ddH2O
计算 重置

技术支持

您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。

Keywords

Nandrolone decanoate 360-70-3 Microbiology/Virology Others Proteases/Proteasome HIV Protease inhibit NMDAr HIV 癸酸诺龙 Human immunodeficiency virus behavior Inhibitor glutamate 19-Nortestosterone decanoate aggressive Androgen Receptor GLT-1 memantine transporter inhibitor

 

TargetMol Loading
陶术
生物
TargetMol®中国区唯一合作伙伴
点击进入陶术生物官网陶术生物
联系我们
400-820-0310

上海市静安区江场三路238号8楼